Published in J Med Chem on January 28, 2010
Privileged scaffolds for library design and drug discovery. Curr Opin Chem Biol (2010) 3.01
Scaffold diversity of exemplified medicinal chemistry space. J Chem Inf Model (2011) 1.11
Synthesis of skeletally diverse alkaloid-like molecules: exploitation of metathesis substrates assembled from triplets of building blocks. Beilstein J Org Chem (2013) 0.82
Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery. Antibiotics (Basel) (2014) 0.80
Exploring target-selectivity patterns of molecular scaffolds. ACS Med Chem Lett (2010) 0.79
Rationalizing structure and target relationships between current drugs. AAPS J (2012) 0.78
PhIN: A Protein Pharmacology Interaction Network Database. CPT Pharmacometrics Syst Pharmacol (2015) 0.76
Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov (2004) 8.10
B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity (2003) 3.47
Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med (2003) 2.66
Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. Drug Discov Today (2007) 1.90
Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. J Med Chem (2008) 1.57
Aptamer displacement identifies alternative small-molecule target sites that escape viral resistance. Chem Biol (2007) 1.52
Molecular similarity in medicinal chemistry. J Med Chem (2013) 1.41
Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation. J Chem Inf Model (2010) 1.40
Identifying mechanism-of-action targets for drugs and probes. Proc Natl Acad Sci U S A (2012) 1.36
What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data. AAPS J (2013) 1.35
Polypharmacology: challenges and opportunities in drug discovery. J Med Chem (2014) 1.35
Compound promiscuity: what can we learn from current data? Drug Discov Today (2013) 1.34
Exploring activity cliffs in medicinal chemistry. J Med Chem (2012) 1.32
Large-scale exploration of bioisosteric replacements on the basis of matched molecular pairs. Future Med Chem (2011) 1.27
Activity landscape representations for structure-activity relationship analysis. J Med Chem (2010) 1.22
MMP-Cliffs: systematic identification of activity cliffs on the basis of matched molecular pairs. J Chem Inf Model (2012) 1.22
Rethinking molecular similarity: comparing compounds on the basis of biological activity. ACS Chem Biol (2012) 1.21
Profile scaling increases the similarity search performance of molecular fingerprints containing numerical descriptors and structural keys. J Chem Inf Comput Sci (2003) 1.20
Virtual screening methods that complement HTS. Comb Chem High Throughput Screen (2004) 1.19
Similarity search profiling reveals effects of fingerprint scaling in virtual screening. J Chem Inf Comput Sci (2004) 1.19
Similarity-potency trees: a method to search for SAR information in compound data sets and derive SAR rules. J Chem Inf Model (2010) 1.18
Quo vadis, virtual screening? A comprehensive survey of prospective applications. J Med Chem (2010) 1.17
A data mining method to facilitate SAR transfer. J Chem Inf Model (2011) 1.17
Entourage: visualizing relationships between biological pathways using contextual subsets. IEEE Trans Vis Comput Graph (2013) 1.14
Large-scale similarity search profiling of ChEMBL compound data sets. J Chem Inf Model (2011) 1.13
Recent progress in understanding activity cliffs and their utility in medicinal chemistry. J Med Chem (2013) 1.12
Understanding chemoinformatics: a unifying approach. Drug Discov Today (2004) 1.09
Chemical substitutions that introduce activity cliffs across different compound classes and biological targets. J Chem Inf Model (2010) 1.08
State-of-the-art in ligand-based virtual screening. Drug Discov Today (2011) 1.07
Growth of ligand-target interaction data in ChEMBL is associated with increasing and activity measurement-dependent compound promiscuity. J Chem Inf Model (2012) 1.07
SAR matrices: automated extraction of information-rich SAR tables from large compound data sets. J Chem Inf Model (2012) 1.06
How promiscuous are pharmaceutically relevant compounds? A data-driven assessment. AAPS J (2012) 1.04
Local structural changes, global data views: graphical substructure-activity relationship trailing. J Med Chem (2011) 1.01
Chemical space networks: a powerful new paradigm for the description of chemical space. J Comput Aided Mol Des (2014) 1.01
Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database. J Chem Inf Model (2012) 1.01
SAR index: quantifying the nature of structure-activity relationships. J Med Chem (2007) 1.01
Lessons learned from molecular scaffold analysis. J Chem Inf Model (2011) 1.00
SARANEA: a freely available program to mine structure-activity and structure-selectivity relationship information in compound data sets. J Chem Inf Model (2010) 0.99
Searching for target-selective compounds using different combinations of multiclass support vector machine ranking methods, kernel functions, and fingerprint descriptors. J Chem Inf Model (2009) 0.97
Systematic mining of analog series with related core structures in multi-target activity space. J Comput Aided Mol Des (2013) 0.97
Rationalizing three-dimensional activity landscapes and the influence of molecular representations on landscape topology and the formation of activity cliffs. J Chem Inf Model (2010) 0.95
Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity. J Med Chem (2012) 0.95
Chemoinformatics: a view of the field and current trends in method development. Bioorg Med Chem (2012) 0.94
Anatomy of fingerprint search calculations on structurally diverse sets of active compounds. J Chem Inf Model (2005) 0.93
Exploration of structure-activity relationship determinants in analogue series. J Med Chem (2009) 0.93
Design of multitarget activity landscapes that capture hierarchical activity cliff distributions. J Chem Inf Model (2011) 0.92
Comparison of confirmed inactive and randomly selected compounds as negative training examples in support vector machine-based virtual screening. J Chem Inf Model (2013) 0.92
New methodologies for ligand-based virtual screening. Curr Pharm Des (2005) 0.91
Identification of the first low-molecular-weight inhibitors of matriptase-2. J Med Chem (2010) 0.90
Cell-based partitioning. Methods Mol Biol (2004) 0.90
Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs. J Chem Inf Model (2010) 0.90
Biodiversity of small molecules--a new perspective in screening set selection. Drug Discov Today (2013) 0.90
Scaffold hopping using two-dimensional fingerprints: true potential, black magic, or a hopeless endeavor? Guidelines for virtual screening. J Med Chem (2010) 0.89
Design and evaluation of a molecular fingerprint involving the transformation of property descriptor values into a binary classification scheme. J Chem Inf Comput Sci (2003) 0.89
Support-vector-machine-based ranking significantly improves the effectiveness of similarity searching using 2D fingerprints and multiple reference compounds. J Chem Inf Model (2008) 0.89
Ligand binding sites of inducible costimulator and high avidity mutants with improved function. J Exp Med (2002) 0.89
Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold. J Med Chem (2010) 0.88
Neighborhood-based prediction of novel active compounds from SAR matrices. J Chem Inf Model (2014) 0.88
Influence of search parameters and criteria on compound selection, promiscuity, and pan assay interference characteristics. J Chem Inf Model (2014) 0.88
Design and evaluation of bonded atom pair descriptors. J Chem Inf Model (2010) 0.87
How do 2D fingerprints detect structurally diverse active compounds? Revealing compound subset-specific fingerprint features through systematic selection. J Chem Inf Model (2011) 0.87
Comparison of 2D fingerprint methods for multiple-template similarity searching on compound activity classes of increasing structural diversity. ChemMedChem (2007) 0.87
Ligand prediction for orphan targets using support vector machines and various target-ligand kernels is dominated by nearest neighbor effects. J Chem Inf Model (2009) 0.87
Support vector machines for drug discovery. Expert Opin Drug Discov (2013) 0.86
Composition and topology of activity cliff clusters formed by bioactive compounds. J Chem Inf Model (2014) 0.85
Atomic resolution studies of carbonic anhydrase II. Acta Crystallogr D Biol Crystallogr (2010) 0.85
Molecular fingerprint recombination: generating hybrid fingerprints for similarity searching from different fingerprint types. ChemMedChem (2009) 0.85
REPROVIS-DB: a benchmark system for ligand-based virtual screening derived from reproducible prospective applications. J Chem Inf Model (2011) 0.85
From activity cliffs to activity ridges: informative data structures for SAR analysis. J Chem Inf Model (2011) 0.85
Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein. J Virol (2005) 0.85
Directed R-group combination graph: a methodology to uncover structure-activity relationship patterns in a series of analogues. J Med Chem (2012) 0.85
Exploring structure-selectivity relationships of biogenic amine GPCR antagonists using similarity searching and dynamic compound mapping. Mol Divers (2008) 0.84
Methods for computer-aided chemical biology. Part 3: analysis of structure-selectivity relationships through single- or dual-step selectivity searching and Bayesian classification. Chem Biol Drug Des (2008) 0.84
Integrating structure- and ligand-based virtual screening: comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets. ChemMedChem (2008) 0.84
Scaffold distributions in bioactive molecules, clinical trials compounds, and drugs. ChemMedChem (2010) 0.84
Bioturbo similarity searching: combining chemical and biological similarity to discover structurally diverse bioactive molecules. J Chem Inf Model (2013) 0.84
Identification of structurally diverse growth hormone secretagogue agonists by virtual screening and structure-activity relationship analysis of 2-formylaminoacetamide derivatives. J Med Chem (2004) 0.84
The future of virtual compound screening. Chem Biol Drug Des (2013) 0.84
Frequency of occurrence and potency range distribution of activity cliffs in bioactive compounds. J Chem Inf Model (2012) 0.84
Systematic identification and classification of three-dimensional activity cliffs. J Chem Inf Model (2012) 0.83
A screening pattern recognition method finds new and divergent targets for drugs and natural products. ACS Chem Biol (2014) 0.83
Ligand prediction from protein sequence and small molecule information using support vector machines and fingerprint descriptors. J Chem Inf Model (2009) 0.83
Elucidation of structure-activity relationship pathways in biological screening data. J Med Chem (2009) 0.83
Introduction of a methodology for visualization and graphical interpretation of Bayesian classification models. J Chem Inf Model (2014) 0.83
A coumarin-labeled vinyl sulfone as tripeptidomimetic activity-based probe for cysteine cathepsins. Chembiochem (2014) 0.83
Emerging chemical patterns: a new methodology for molecular classification and compound selection. J Chem Inf Model (2006) 0.83
Development of a compound class-directed similarity coefficient that accounts for molecular complexity effects in fingerprint searching. J Chem Inf Model (2009) 0.83
Design and characterization of chemical space networks for different compound data sets. J Comput Aided Mol Des (2014) 0.83
Systematic computational analysis of structure-activity relationships: concepts, challenges and recent advances. Future Med Chem (2009) 0.83
Chemical descriptors with distinct levels of information content and varying sensitivity to differences between selected compound databases identified by SE-DSE analysis. J Chem Inf Comput Sci (2002) 0.82
A homogeneous fluorescence resonance energy transfer system for monitoring the activation of a protein switch in real time. J Am Chem Soc (2011) 0.82
BindingDB and ChEMBL: online compound databases for drug discovery. Expert Opin Drug Discov (2011) 0.82
Targeting multifunctional proteins by virtual screening: structurally diverse cytohesin inhibitors with differentiated biological functions. ACS Chem Biol (2010) 0.82
Molecular scaffolds with high propensity to form multi-target activity cliffs. J Chem Inf Model (2010) 0.82
Quantifying the fingerprint descriptor dependence of structure-activity relationship information on a large scale. J Chem Inf Model (2013) 0.82
Computational analysis of multi-target structure-activity relationships to derive preference orders for chemical modifications toward target selectivity. ChemMedChem (2010) 0.82